• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I期和II期口腔舌鳞状细胞癌患者的预后较差。

Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.

作者信息

Rusthoven Kyle, Ballonoff Ari, Raben David, Chen Changhu

机构信息

Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado 80045-0508, USA.

出版信息

Cancer. 2008 Jan 15;112(2):345-51. doi: 10.1002/cncr.23183.

DOI:10.1002/cncr.23183
PMID:18041071
Abstract

BACKGROUND

The objective of this study was to compare survival in patients with squamous cell carcinoma (SCC) of the oral tongue with that in patients with SCC in other oral cavity subsites.

METHODS

Patients with stage I and II (T1-T2N0M0) SCC of the oral cavity diagnosed between 1988 and 2004 were queried by using the Surveillance, Epidemiology, and End Results (SEER) database. The log-rank test was used to compare the overall survival (OS) and cause-specific survival (CSS) of patients who had oral tongue SCC with those of patients who had SCC of other oral cavity subsites. A Cox proportional hazards multivariate analysis was performed to evaluate the influence of covariates on the risk of CSS and OS.

RESULTS

Between 1988 and 2004, 6791 patients with stage I and II SCC of the oral cavity were identified. Among them, 40% had oral tongue SCC, and 60% had SCC of other oral cavity subsites. The median patient age was 64 years. The 5-year OS and CSS rates were 60.9% and 83.5%, respectively, for patients with oral tongue SCC versus 64.7% and 94.1%, respectively, for patients with SCC of other oral cavity subsites (OS: hazard ratio, 1.24; P< .0001; CSS: hazard ratio, 3.04; P< .0001). On multivariate analysis, OS and CSS were influenced significantly by T classification, age, sex, and oral tongue subsite. The CSS for patients who had stage I and II oral tongue SCC also was unfavorable compared with the CSS for stage-matched patients who had SCC of other head and neck sites.

CONCLUSIONS

Oral tongue SCC was associated with poor survival compared with other oral cavity and head and neck sites. These data suggested a potential benefit for multimodality therapy in this cohort of patients.

摘要

背景

本研究的目的是比较口腔舌鳞状细胞癌(SCC)患者与其他口腔亚部位SCC患者的生存率。

方法

利用监测、流行病学和最终结果(SEER)数据库查询1988年至2004年间诊断为I期和II期(T1 - T2N0M0)口腔SCC的患者。采用对数秩检验比较口腔舌SCC患者与其他口腔亚部位SCC患者的总生存期(OS)和病因特异性生存期(CSS)。进行Cox比例风险多变量分析以评估协变量对CSS和OS风险的影响。

结果

在1988年至2004年间,确定了6791例I期和II期口腔SCC患者。其中,40%患有口腔舌SCC,60%患有其他口腔亚部位SCC。患者中位年龄为64岁。口腔舌SCC患者的5年OS率和CSS率分别为60.9%和83.5%,而其他口腔亚部位SCC患者分别为64.7%和94.1%(OS:风险比,1.24;P <.0001;CSS:风险比,3.04;P <.0001)。多变量分析显示,OS和CSS受T分类、年龄、性别和口腔舌亚部位的显著影响。与其他头颈部部位SCC的分期匹配患者相比,I期和II期口腔舌SCC患者的CSS也较差。

结论

与其他口腔及头颈部部位相比,口腔舌SCC与较差的生存率相关。这些数据表明对该组患者进行多模式治疗可能有益。

相似文献

1
Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.I期和II期口腔舌鳞状细胞癌患者的预后较差。
Cancer. 2008 Jan 15;112(2):345-51. doi: 10.1002/cncr.23183.
2
[Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].[229例晚期舌鳞状细胞癌患者的生存分析]
Ai Zheng. 2008 Dec;27(12):1315-20.
3
Survival and patterns of relapse in patients with oral tongue cancer.口腔舌癌患者的生存情况及复发模式
J Oral Maxillofac Surg. 2010 Mar;68(3):584-9. doi: 10.1016/j.joms.2009.03.056. Epub 2009 Nov 25.
4
[Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].[125例cT1-2N0期舌鳞状细胞癌患者术后复发相关因素分析]
Ai Zheng. 2007 Jun;26(6):661-5.
5
Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.早期舌癌对侧N0颈部的治疗:选择性颈部清扫术与观察对比
Laryngoscope. 2006 Mar;116(3):461-5. doi: 10.1097/01.mlg.0000195366.91395.9b.
6
Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?舌癌:与口腔其他亚部位相比,其生存率是否存在差异?
J Oral Maxillofac Surg. 2007 Feb;65(2):229-36. doi: 10.1016/j.joms.2005.11.094.
7
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.舌癌和扁桃体癌:美国20至44岁人群中的上升趋势。
Cancer. 2005 May 1;103(9):1843-9. doi: 10.1002/cncr.20998.
8
Survival in patients under 45 years with squamous cell carcinoma of the oral tongue.45岁以下舌鳞状细胞癌患者的生存率。
Int J Oral Maxillofac Surg. 2003 Apr;32(2):167-73. doi: 10.1054/ijom.2002.0271.
9
[Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue].[舌部cN0期鳞状细胞癌预后预测指标的多因素分析]
Ai Zheng. 2003 Feb;22(2):206-9.
10
Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors.口腔舌鳞状细胞癌:预后因素分析
Br J Oral Maxillofac Surg. 2000 Jun;38(3):193-9. doi: 10.1054/bjom.1999.0235.

引用本文的文献

1
A SEER-based prognostic nomogram for early-stage (pT1-2N0M0) tongue squamous cell carcinoma and an observational analysis of postoperative radiotherapy.基于监测、流行病学与最终结果(SEER)数据库的早期(pT1-2N0M0)舌鳞状细胞癌预后列线图及术后放疗的观察性分析
World J Surg Oncol. 2025 Jul 25;23(1):302. doi: 10.1186/s12957-025-03883-2.
2
Tongue squamous cell carcinoma-derived exosomes miR-21-5p affect tumor progression via promoting M2 macrophage polarization.舌鳞状细胞癌来源的外泌体miR-21-5p通过促进M2巨噬细胞极化影响肿瘤进展。
Noncoding RNA Res. 2025 May 15;13:184-196. doi: 10.1016/j.ncrna.2025.05.006. eCollection 2025 Aug.
3
Long-term oncologic outcomes and prognostic factors related to recurrences in pathologic Stage I/II early oral tongue cancer.
与病理I/II期早期口腔舌癌复发相关的长期肿瘤学结局及预后因素。
Front Surg. 2025 May 21;12:1534274. doi: 10.3389/fsurg.2025.1534274. eCollection 2025.
4
Evaluation of survival rate in patients with tongue squamous cell carcinoma: a retrospective single-center study.舌鳞状细胞癌患者生存率评估:一项回顾性单中心研究
BMC Oral Health. 2025 Apr 29;25(1):658. doi: 10.1186/s12903-025-05850-5.
5
Risk of early death after treatment with curative intent for head and neck squamous cell carcinoma: a retrospective population-based study.头颈部鳞状细胞癌根治性治疗后的早期死亡风险:一项基于人群的回顾性研究。
Acta Oncol. 2025 Mar 4;64:339-348. doi: 10.2340/1651-226X.2025.42202.
6
Influence of Health System Affiliation and Pain Manifestation on Advanced Oral Cavity Squamous Cell Carcinoma Risk: A Retrospective Cohort Study in a Latin American Population.卫生系统归属和疼痛表现对晚期口腔鳞状细胞癌风险的影响:拉丁美洲人群的一项回顾性队列研究
Dent J (Basel). 2024 Nov 26;12(12):383. doi: 10.3390/dj12120383.
7
Epidemiological landscape of tongue cancer in younger patients in a National Cancer Center in Brazil.巴西国家癌症中心年轻患者舌癌的流行病学概况
Sci Rep. 2024 Dec 20;14(1):30573. doi: 10.1038/s41598-024-83470-9.
8
Prognostic Implications of the Number of Lymph Node Metastases in Oral Tongue Squamous Cell Carcinoma: A Population Study of the SEER Database and an Institutional Registry.口腔舌鳞状细胞癌淋巴结转移数量的预后意义:一项基于监测、流行病学和最终结果(SEER)数据库及机构登记处的人群研究
Cancer Med. 2024 Dec;13(24):e70493. doi: 10.1002/cam4.70493.
9
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.口腔癌预后研究的荟萃分析积累的证据:迈向生物标志物驱动的患者选择。
BMC Cancer. 2024 Dec 18;24(1):1517. doi: 10.1186/s12885-024-13317-z.
10
Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India.口腔舌鳞状细胞癌 upfront 手术切除患者的预后及影响因素:来自印度北部三级医疗中心的经验
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4479-4486. doi: 10.1007/s12070-024-04889-0. Epub 2024 Jul 13.